{ "items" : [
    { "id" : "http://dbpedia.org/resource/AM-2201"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University." ] ,
        "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ "http://dbpedia.org/resource/JWH-018" ] ,
        "http://xmlns.com/foaf/0.1/depiction" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/AM-2201_structure.png" ] ,
        "http://dbpedia.org/ontology/casNumber" : [ "335161-24-5" ] ,
        "http://dbpedia.org/ontology/iupacName" : [ "1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone" ] ,
        "http://dbpedia.org/ontology/thumbnail" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/AM-2201_structure.png?width=300"] } } }
